Compare ATYR & ACFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATYR | ACFN |
|---|---|---|
| Founded | 2005 | 1986 |
| Country | United States | United States |
| Employees | 58 | 27 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.1M | 40.0M |
| IPO Year | N/A | N/A |
| Metric | ATYR | ACFN |
|---|---|---|
| Price | $0.57 | $16.33 |
| Analyst Decision | Hold | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $3.67 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 6.4K |
| Earning Date | 05-01-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.63 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.40 | $12.42 |
| 52 Week High | $7.29 | $33.00 |
| Indicator | ATYR | ACFN |
|---|---|---|
| Relative Strength Index (RSI) | 55.20 | 47.75 |
| Support Level | $0.42 | $15.87 |
| Resistance Level | $0.59 | $17.20 |
| Average True Range (ATR) | 0.04 | 0.76 |
| MACD | 0.02 | 0.08 |
| Stochastic Oscillator | 93.47 | 59.41 |
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. The company operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.